Protalix Biotherapeutics Inc. buy melinda
Start price
23.09.13
/
50%
€32.52
Target price
24.03.14
€40.00
Performance (%)
2.15%
End price
24.03.14
€33.22
Summary
This prediction ended on 24.03.14 with a price of €33.22. With a performance of 2.15%, the BUY prediction by melinda for Protalix Biotherapeutics Inc. closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Protalix Biotherapeutics Inc. | 2.312% | 2.312% | -15.754% | 20.408% |
| iShares Core DAX® | 0.336% | 4.366% | 21.868% | 63.911% |
| iShares Nasdaq 100 | 0.541% | 3.170% | 7.017% | 108.934% |
| iShares Nikkei 225® | 4.048% | 6.727% | 22.855% | 57.329% |
| iShares S&P 500 | 0.795% | 3.281% | 4.698% | 67.940% |
According to melinda what are the pros and cons of Protalix Biotherapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Protalix Biotherapeutics Inc. diskutieren
Übersetzung fehlgeschlagen
Die Übersetzung durch Google Translate ist leider fehlgeschlagen.
(Laufzeit überschritten)
Stopped prediction by melinda for Protalix Biotherapeutics Inc.
Protalix Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€1.56
28.12.25
28.12.25
-
28.12.26
28.12.26
-1.28%
03.01.26
03.01.26
Could be worthwhile Investment >10% per year
Protalix Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€1.63
27.12.23
27.12.23
€2.00
27.12.24
27.12.24
9.02%
28.12.24
28.12.24
Protalix Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€7.24
17.05.17
17.05.17
€9.00
25.05.17
25.05.17
12.85%
25.05.17
25.05.17
Protalix Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€6.96
02.06.16
02.06.16
€12.00
02.12.16
02.12.16
-22.13%
02.12.16
02.12.16